Recent News

• 03.20.2025 - Adaptimmune Provides Q4 and Full Year 2024 Business Update
• 03.12.2025 - Adaptimmune to Report Full Year and Q4 2024 Financial and Business Updates on Thursday, March 20, 2025
• 01.30.2025 - Adaptimmune to Participate in the Guggenheim Securities SMID Cap Biotech Conference February 6, 2025

Recent Filings

• 03.20.2025 - 8-K Current report
• 03.20.2025 - EX-99.1 EX-99.1
• 02.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.14.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 02.12.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors